Skip to main content

Posts

Showing posts with the label Tempus AI Inc.

Featured Post

Market Daily Report: Bursa Malaysia Ends Nearly Flat As Construction Stocks Attract Buying

 KUALA LUMPUR, Sept 8 (Bernama) -- Bursa Malaysia closed almost flat on Tuesday as buying interest rotated away from index heavyweights towards smaller-cap construction stocks, with sentiment affected by geopolitical uncertainty, said an analyst. At 5 pm, the FTSE Bursa Malaysia KLCI (FBM KLCI) eased 0.39 of a point to 1,714.40 from Monday’s close of 1,714.79. The benchmark index opened 1.65 points lower at 1,713.14 and moved between 1,710.44 and 1,714.50 throughout the trading session. The broader market was almost evenly balanced, with decliners leading gainers 548 to 546, while 598 counters were unchanged, 1,107 were untraded and 25 were suspended. Turnover expanded to 4.13 billion units valued at RM3.14 billion from 3.60 billion units valued at RM2.45 billion on Monday.

Cathie Wood Doubles Down on Tempus AI as Shares Surge Over 76% YTD

Tempus AI Inc. (NASDAQ: TEM)  continues to draw strong interest from institutional investors, with  Cathie Wood’s ARK Invest  adding to its position in the precision health tech company. In its latest move,  ARK Investment Management purchased 150,563 shares , valued at approximately  US$8.8 million . The majority were acquired through the flagship  ARK Innovation ETF (ARKK) , with a smaller tranche via the  ARK Genomic Revolution ETF (ARKG)  — signaling continued conviction in Tempus’ AI-driven healthcare model. A separate  US$1 million worth of shares  was also added, highlighting ARK's sustained bullish stance. Strategic Expansion in Cancer Detection Tempus has recently  expanded its collaboration with Personalis Inc.  to include  colorectal cancer , alongside existing work in  breast ,  lung , and  immunotherapy monitoring . This bolsters the commercialization of the  NeXT Personal™ MRD (Minimal Res...